CCM
XENT

Cinctive Capital Management’s Intersect ENT, Inc XENT Stock Holding History

Cinctive Capital Management’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-12,000
Closed -$205K – 687
2021
Q2 		$205K Buy
+12,000
New +$225K 0.01% 454

Other funds holding XENT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cinctive Capital Management's XENT Position: Q3 2021 in Review

Cinctive Capital Management sold out of Intersect ENT, Inc (XENT) in Q3 2021, closing a stake of 12,000 shares — an estimated $205K sold.

Cinctive Capital Management first reported a position in XENT in Q2 2021 and held it in 1 quarter. The position peaked at $205K in Q2 2021. 123 funds tracked by Wall St. Rank hold XENT as of Q3 2021.

  • Cinctive Capital Management reported no remaining Intersect ENT, Inc position as of Q3 2021 after selling out during the quarter.
  • Cinctive Capital Management sold 12,000 Intersect ENT, Inc shares in Q3 2021, an estimated $205K.
  • Cinctive Capital Management first reported a position in Intersect ENT, Inc in Q2 2021 and held it in 1 quarter.
  • Cinctive Capital Management's Intersect ENT, Inc position peaked at $205K in Q2 2021.
  • 123 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2021.

Based on Cinctive Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.